Dr. Nathan D. Nielsen is an Associate Professor of Medicine and Pathology in the Division of Pulmonary, Critical Care, and Sleep Medicine and the Section of Transfusion Medicine and Therapeutic Pathology at the University of New Mexico School of Medicine. He is one of a handful of physicians in the United States with medical board certification in both Critical Care Medicine and Transfusion Medicine. He is a dedicated member of the Systemic Inflammation and Sepsis and Global Intensive Care sections and the Transfusion Medicine working group of the European Society of Intensive Care Medicine (ESICM) and presently serves as the Executive Editor of the ESICM Academy. He has been a faculty expert for all iterations of ESICM’s Sepsis and Severe Infections master class and co-directs ESICM’s Research Learning Pathway. He is an active supporter of the Global Sepsis Alliance, serving as the Scientific Content Editor for GSA publications and documents. Nathan is a published clinical and translational researcher in the field of Disseminated Intravascular Coagulation (DIC), and a senior investigator in several sepsis clinical trials.
Dr. Andrew Conway Morris is a practicing intensive care physician and clinician scientist whose research focuses on severe infections in intensive care patients. He is interested in how the immune system fails in
critical illness and how this leads to infections, most especially pneumonia. He undertook degrees in medicine and biomedical science at the University of Glasgow before moving to Edinburgh where he completed a PhD in critical care immunology, identifying the complement component C5a as a key mediator in neutrophil dysfunction in critically ill patients. After a period as a Clinical Lecturer in Intensive Care Medicine at the University of Edinburgh, he moved to Cambridge to take up an NIHR Academic Clinical Lectureship, followed by a Wellcome Trust Clinical Research Career Development Fellowship. He is currently an MRC Clinician Scientist in the Department of Medicine and a Visiting Scientist in the Department of Pathology, where he works closely with Klaus Okkenhaug’s group in a shared lab space. His group in the Department of Pathology seeks to understand the signaling pathways that underpin the
neutrophil response to pathogens, and how these are disrupted in critical illness and sepsis.
Prof. Dr. Pedro Povoa is a Full Professor at the NOVA Medical School, New University of Lisbon, Portugal, and an Adjunct Professor at the Center for Clinical Epidemiology and Research Unit of Clinical Epidemiology, OUH Odense University Hospital, Denmark. He serves as the` President of the Infection Section, European Society of Intensive Care Medicine, a Chair of the INF Section, European Society of Intensive Care Medicine, a Coordinator of the Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, CHLO, Lisbon, Portugal, an Associate Editor of the Official Journal of AMIB. His research topics mainly include Infection, Intensive Care Units, Pneumonia, Sepsis, Biomarkers, and Mechanical Ventilation.
Dr. Jeroen Schouten is an internist and intensivist and a senior researcher at Radboud University Nijmegen Medical Centre in Nijmegen, the Netherlands. He earned a Ph.D. in Infectious Diseases and Implementation Science and has been involved in qualitative research with a focus on antimicrobial stewardship ever since. As a senior researcher, he has performed numerous studies on understanding and improving hospital antimicrobial use. He is experienced in qualitative and quantitative research methods and has been involved in many international initiatives to improve antibiotic prescribing. He heads the Radboud University Nijmegen Medical Centre Antimicrobial Stewardship Program (ASP) and is course director of the Dutch Masterclass for Antimicrobial Stewardship and Expert Consultancy, an International program that focuses on the step-wise implementation of AMS activities in healthcare institutions. He is currently chair at ESGAP (ESCMID Study Group of Antimicrobial Stewardship) and coordinates the ESCMID Certificate European Training Program for Antimicrobial Stewardship. He is also a member of the Executive Committee at APUA.
